001     139067
005     20240416115859.0
024 7 _ |a 10.1002/humu.23161
|2 doi
024 7 _ |a pmid:28008748
|2 pmid
024 7 _ |a pmc:PMC5324646
|2 pmc
024 7 _ |a 1059-7794
|2 ISSN
024 7 _ |a 1098-1004
|2 ISSN
024 7 _ |a altmetric:15149551
|2 altmetric
037 _ _ |a DZNE-2020-05389
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a van der Zee, Julie
|b 0
245 _ _ |a TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
260 _ _ |a New York, NY [u.a.]
|c 2017
|b Wiley-Liss
264 _ 1 |3 online
|2 Crossref
|b Wiley
|c 2017-01-19
264 _ 1 |3 print
|2 Crossref
|b Wiley
|c 2017-03-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1713192440_9657
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a We investigated the mutation spectrum of the TANK-Binding Kinase 1 (TBK1) gene and its associated phenotypic spectrum by exonic resequencing of TBK1 in a cohort of 2,538 patients with frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), or FTD plus ALS, ascertained within the European Early-Onset Dementia Consortium. We assessed pathogenicity of predicted protein-truncating mutations by measuring loss of RNA expression. Functional effect of in-frame amino acid deletions and missense mutations was further explored in vivo on protein level and in vitro by an NFκB-induced luciferase reporter assay and measuring phosphorylated TBK1. The protein-truncating mutations led to the loss of transcript through nonsense-mediated mRNA decay. For the in-frame amino acid deletions, we demonstrated loss of TBK1 or phosphorylated TBK1 protein. An important fraction of the missense mutations compromised NFκB activation indicating that at least some functions of TBK1 are lost. Although missense mutations were also present in controls, over three times more mutations affecting TBK1 functioning were found in the mutation fraction observed in patients only, suggesting high-risk alleles (P = 0.03). Total mutation frequency for confirmed TBK1 LoF mutations in the European cohort was 0.7%, with frequencies in the clinical subgroups of 0.4% in FTD, 1.3% in ALS, and 3.6% in FTD-ALS.
536 _ _ |a 345 - Population Studies and Genetics (POF3-345)
|0 G:(DE-HGF)POF3-345
|c POF3-345
|f POF III
|x 0
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 1
542 _ _ |i 2017-01-19
|2 Crossref
|u http://doi.wiley.com/10.1002/tdm_license_1.1
542 _ _ |i 2017-01-19
|2 Crossref
|u http://creativecommons.org/licenses/by-nc-nd/4.0/
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a NF-kappa B
|2 NLM Chemicals
650 _ 7 |a Protein-Serine-Threonine Kinases
|0 EC 2.7.11.1
|2 NLM Chemicals
650 _ 7 |a TBK1 protein, human
|0 EC 2.7.11.1
|2 NLM Chemicals
650 _ 2 |a Protein Serine-Threonine Kinases: genetics
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Alleles
|2 MeSH
650 _ 2 |a Amino Acid Substitution
|2 MeSH
650 _ 2 |a Amyotrophic Lateral Sclerosis: diagnosis
|2 MeSH
650 _ 2 |a Amyotrophic Lateral Sclerosis: epidemiology
|2 MeSH
650 _ 2 |a Amyotrophic Lateral Sclerosis: genetics
|2 MeSH
650 _ 2 |a Case-Control Studies
|2 MeSH
650 _ 2 |a Cohort Studies
|2 MeSH
650 _ 2 |a Enzyme Activation
|2 MeSH
650 _ 2 |a European Continental Ancestry Group: genetics
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Frontotemporal Dementia: diagnosis
|2 MeSH
650 _ 2 |a Frontotemporal Dementia: epidemiology
|2 MeSH
650 _ 2 |a Frontotemporal Dementia: genetics
|2 MeSH
650 _ 2 |a Genetic Association Studies
|2 MeSH
650 _ 2 |a Heterozygote
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Mutation
|2 MeSH
650 _ 2 |a NF-kappa B: metabolism
|2 MeSH
650 _ 2 |a Phenotype
|2 MeSH
650 _ 2 |a Protein-Serine-Threonine Kinases: genetics
|2 MeSH
650 _ 2 |a Protein-Serine-Threonine Kinases: metabolism
|2 MeSH
650 _ 2 |a Sequence Deletion
|2 MeSH
650 _ 2 |a Protein Serine-Threonine Kinases: metabolism
|2 MeSH
650 _ 2 |a White People: genetics
|2 MeSH
700 1 _ |a Gijselinck, Ilse
|b 1
700 1 _ |a Van Mossevelde, Sara
|b 2
700 1 _ |a Perrone, Federica
|b 3
700 1 _ |a Dillen, Lubina
|b 4
700 1 _ |a Heeman, Bavo
|b 5
700 1 _ |a Bäumer, Veerle
|b 6
700 1 _ |a Engelborghs, Sebastiaan
|b 7
700 1 _ |a De Bleecker, Jan
|b 8
700 1 _ |a Baets, Jonathan
|b 9
700 1 _ |a Gelpi, Ellen
|b 10
700 1 _ |a Rojas-García, Ricardo
|b 11
700 1 _ |a Clarimón, Jordi
|b 12
700 1 _ |a Lleó, Alberto
|b 13
700 1 _ |a Diehl-Schmid, Janine
|0 P:(DE-HGF)0
|b 14
700 1 _ |a Alexopoulos, Panagiotis
|b 15
700 1 _ |a Perneczky, Robert
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Synofzik, Matthis
|0 P:(DE-2719)2811275
|b 17
|u dzne
700 1 _ |a Just, Jennifer
|0 P:(DE-2719)2811826
|b 18
|u dzne
700 1 _ |a Schöls, Ludger
|0 P:(DE-2719)2810795
|b 19
|u dzne
700 1 _ |a Graff, Caroline
|b 20
700 1 _ |a Thonberg, Håkan
|b 21
700 1 _ |a Borroni, Barbara
|b 22
700 1 _ |a Padovani, Alessandro
|b 23
700 1 _ |a Jordanova, Albena
|b 24
700 1 _ |a Sarafov, Stayko
|b 25
700 1 _ |a Tournev, Ivailo
|b 26
700 1 _ |a de Mendonça, Alexandre
|b 27
700 1 _ |a Miltenberger-Miltényi, Gabriel
|b 28
700 1 _ |a Simões do Couto, Frederico
|b 29
700 1 _ |a Ramirez, Alfredo
|0 P:(DE-HGF)0
|b 30
700 1 _ |a Jessen, Frank
|0 P:(DE-2719)2000032
|b 31
|u dzne
700 1 _ |a Heneka, Michael T
|0 P:(DE-2719)2000008
|b 32
|u dzne
700 1 _ |a Gómez-Tortosa, Estrella
|b 33
700 1 _ |a Danek, Adrian
|0 P:(DE-2719)2810712
|b 34
|u dzne
700 1 _ |a Cras, Patrick
|b 35
700 1 _ |a Vandenberghe, Rik
|b 36
700 1 _ |a De Jonghe, Peter
|b 37
700 1 _ |a De Deyn, Peter P
|b 38
700 1 _ |a Sleegers, Kristel
|b 39
700 1 _ |a Cruts, Marc
|b 40
700 1 _ |a Van Broeckhoven, Christine
|0 P:(DE-HGF)0
|b 41
|e Corresponding author
700 1 _ |a Goeman, Johan
|b 42
700 1 _ |a Nuytten, Dirk
|b 43
700 1 _ |a Smets, Katrien
|b 44
700 1 _ |a Robberecht, Wim
|b 45
700 1 _ |a Damme, Philip Van
|b 46
700 1 _ |a Bleecker, Jan De
|b 47
700 1 _ |a Santens, Patrick
|b 48
700 1 _ |a Dermaut, Bart
|b 49
700 1 _ |a Versijpt, Jan
|b 50
700 1 _ |a Michotte, Alex
|b 51
700 1 _ |a Ivanoiu, Adrian
|b 52
700 1 _ |a Deryck, Olivier
|b 53
700 1 _ |a Bergmans, Bruno
|b 54
700 1 _ |a Delbeck, Jean
|b 55
700 1 _ |a Bruyland, Marc
|b 56
700 1 _ |a Willems, Christiana
|b 57
700 1 _ |a Salmon, Eric
|b 58
700 1 _ |a Pastor, Pau
|b 59
700 1 _ |a Ortega-Cubero, Sara
|b 60
700 1 _ |a Benussi, Luisa
|b 61
700 1 _ |a Ghidoni, Roberta
|b 62
700 1 _ |a Binetti, Giuliano
|b 63
700 1 _ |a Hernández, Isabel
|b 64
700 1 _ |a Boada, Mercè
|b 65
700 1 _ |a Ruiz, Agustín
|b 66
700 1 _ |a Sorbi, Sandro
|b 67
700 1 _ |a Nacmias, Benedetta
|b 68
700 1 _ |a Bagnoli, Silvia
|b 69
700 1 _ |a Sorbi, Sandro
|b 70
700 1 _ |a Sanchez-Valle, Raquel
|b 71
700 1 _ |a Llado, Albert
|b 72
700 1 _ |a Santana, Isabel
|b 73
700 1 _ |a Rosário Almeida, Maria
|b 74
700 1 _ |a Frisoni, Giovanni B
|b 75
700 1 _ |a Maetzler, Walter
|0 P:(DE-HGF)0
|b 76
700 1 _ |a Matej, Radoslav
|b 77
700 1 _ |a Fraidakis, Matthew J
|b 78
700 1 _ |a Kovacs, Gabor G
|b 79
700 1 _ |a Fabrizi, Gian Maria
|b 80
700 1 _ |a Testi, Silvia
|b 81
773 1 8 |a 10.1002/humu.23161
|b : Wiley, 2017-01-19
|n 3
|p 297-309
|3 journal-article
|2 Crossref
|t Human Mutation
|v 38
|y 2017
|x 1059-7794
773 _ _ |a 10.1002/humu.23161
|g Vol. 38, no. 3, p. 297 - 309
|0 PERI:(DE-600)1498165-8
|n 3
|q 38:3<297 - 309
|p 297-309
|t Human mutation
|v 38
|y 2017
|x 1059-7794
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/139067/files/DZNE-2020-05389.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/139067/files/DZNE-2020-05389.pdf?subformat=pdfa
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324646
909 C O |o oai:pub.dzne.de:139067
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 17
|6 P:(DE-2719)2811275
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 18
|6 P:(DE-2719)2811826
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 19
|6 P:(DE-2719)2810795
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 31
|6 P:(DE-2719)2000032
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 32
|6 P:(DE-2719)2000008
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 34
|6 P:(DE-2719)2810712
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-345
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Population Studies and Genetics
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 1
914 1 _ |y 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-22
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b HUM MUTAT : 2021
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-22
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-22
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-22
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-22
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-22
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 0
920 1 _ |0 I:(DE-2719)5000005
|k AG Schöls
|l Clinical Neurogenetics
|x 1
920 1 _ |0 I:(DE-2719)1011102
|k AG Jessen
|l Clinical Alzheimer’s Disease Research
|x 2
920 1 _ |0 I:(DE-2719)1011303
|k AG Heneka ; AG Heneka
|l Neuroinflammation, Biomarker
|x 3
920 1 _ |0 I:(DE-2719)7000003
|k U Clinical Researchers - München
|l U Clinical Researchers - München
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a I:(DE-2719)5000005
980 _ _ |a I:(DE-2719)1011102
980 _ _ |a I:(DE-2719)1011303
980 _ _ |a I:(DE-2719)7000003
980 1 _ |a FullTexts
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-013-1110-0
|2 Crossref
|o 10.1007/s00401-013-1110-0
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neurobiolaging.2015.08.009
|2 Crossref
|o 10.1016/j.neurobiolaging.2015.08.009
999 C 5 |9 -- missing cx lookup --
|a 10.1002/humu.21100
|2 Crossref
|o 10.1002/humu.21100
999 C 5 |9 -- missing cx lookup --
|a 10.1080/146608200300079536
|2 Crossref
|o 10.1080/146608200300079536
999 C 5 |9 -- missing cx lookup --
|a 10.3109/17482968.2012.690418
|2 Crossref
|o 10.3109/17482968.2012.690418
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.aaa3650
|2 Crossref
|o 10.1126/science.aaa3650
999 C 5 |9 -- missing cx lookup --
|a 10.1038/cr.2008.273
|2 Crossref
|o 10.1038/cr.2008.273
999 C 5 |9 -- missing cx lookup --
|a 10.1002/humu.22117
|2 Crossref
|o 10.1002/humu.22117
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.tins.2013.04.010
|2 Crossref
|o 10.1016/j.tins.2013.04.010
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2011.09.011
|2 Crossref
|o 10.1016/j.neuron.2011.09.011
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nn.4000
|2 Crossref
|o 10.1038/nn.4000
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-008-0463-2
|2 Crossref
|o 10.1007/s00401-008-0463-2
999 C 5 |9 -- missing cx lookup --
|a 10.1111/nan.12063
|2 Crossref
|o 10.1111/nan.12063
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S1474-4422(11)70261-7
|2 Crossref
|o 10.1016/S1474-4422(11)70261-7
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.0000000000002220
|2 Crossref
|o 10.1212/WNL.0000000000002220
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.0b013e31821103e6
|2 Crossref
|o 10.1212/WNL.0b013e31821103e6
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2010.11.036
|2 Crossref
|o 10.1016/j.neuron.2010.11.036
999 C 5 |9 -- missing cx lookup --
|a 10.1038/ng.132
|2 Crossref
|o 10.1038/ng.132
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.1166066
|2 Crossref
|o 10.1126/science.1166066
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.0b013e3181ccc732
|2 Crossref
|o 10.1212/WNL.0b013e3181ccc732
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.celrep.2013.01.034
|2 Crossref
|o 10.1016/j.celrep.2013.01.034
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.59.7.1077
|2 Crossref
|o 10.1212/WNL.59.7.1077
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-011-0845-8
|2 Crossref
|o 10.1007/s00401-011-0845-8
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awv358
|2 Crossref
|o 10.1093/brain/awv358
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.51.6.1546
|2 Crossref
|o 10.1212/WNL.51.6.1546
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neurobiolaging.2009.07.009
|2 Crossref
|o 10.1016/j.neurobiolaging.2009.07.009
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.immuni.2012.04.015
|2 Crossref
|o 10.1016/j.immuni.2012.04.015
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-015-1436-x
|2 Crossref
|o 10.1007/s00401-015-1436-x
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awr179
|2 Crossref
|o 10.1093/brain/awr179
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2011.09.010
|2 Crossref
|o 10.1016/j.neuron.2011.09.010
999 C 5 |9 -- missing cx lookup --
|a 10.1093/jnen/63.9.911
|2 Crossref
|o 10.1093/jnen/63.9.911
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.1154584
|2 Crossref
|o 10.1126/science.1154584
999 C 5 |9 -- missing cx lookup --
|a 10.1038/ng1332
|2 Crossref
|o 10.1038/ng1332
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neurobiolaging.2015.08.013
|2 Crossref
|o 10.1016/j.neurobiolaging.2015.08.013
999 C 5 |9 -- missing cx lookup --
|a 10.1002/humu.22244
|2 Crossref
|o 10.1002/humu.22244
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-014-1298-7
|2 Crossref
|o 10.1007/s00401-014-1298-7


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21